STAT+: Investor Clive Meanwell on designing biotechs for population health, and AI’s role as a catalyst
Clive Meanwell, chairman of investment firm Population Health Partners, was an AI skeptic until recently.
Now, he thinks it's a catalyst.
Clive Meanwell, chairman of investment firm Population Health Partners, was an AI skeptic until recently.
Now, he thinks it's a catalyst.